Tempol (4-hydroxy tempo) protects mice from cisplatin-induced acute kidney injuryviamodulation of expression of aquaporins and kidney injury molecule-1

被引:9
作者
Afjal, Mohd Amir [1 ]
Goswami, Poonam [1 ]
Ahmad, Shahzad [1 ]
Dabeer, Sadaf [1 ]
Akhter, Juheb [1 ]
Salman, Mohd [2 ]
Mangla, Anuradha [1 ]
Raisuddin, Sheikh [1 ]
机构
[1] Jamia Hamdard, Dept Med Elementol & Toxicol, Mol Toxicol Lab, New Delhi, India
[2] Jamia Hamdard, Dept Med Elementol & Toxicol, Mol Neurobiol Lab, New Delhi, India
关键词
Anti-neoplastic drug; acute kidney injury; electrolyte imbalance; nephric reabsorption; nephroprotection; ENDOPLASMIC-RETICULUM STRESS; INDUCED NEPHROTOXICITY; OXIDATIVE STRESS; WATER CHANNELS; RAT MODEL; VASOPRESSIN; MECHANISMS; BIOMARKERS; DECREASES; ALPHA;
D O I
10.1080/01480545.2020.1831011
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Tempol (4-hydroxy tempo), a pleiotropic antioxidant is reported to afford protection against cisplatin (CP)-induced nephrotoxicity. However, molecular mechanisms of action of tempol in improving the renal function in CP-induced nephrotoxicity are not fully understood. We investigated the attenuating effect of tempol against CP-induced alterations in kidney injury molecule-1 (KIM-1) and aquaporins (AQPs) in mice. Tempol (100 mg/kg,po) pretreatment with CP (20 mg/kgip) showed restoration in renal function markers including electrolytes. CP treatment upregulated mRNA expression of KIM-1 and downregulated AQP and arginine vasopressin (AVP) expression which was attenuated by tempol. Immunoblotting analysis revealed that CP-induced alterations in KIM-1 and AQP expression were restored by tempol. Immunofluorocense study also showed restorative effect of tempol on the expression of AQP2 in CP-treated mice. In conclusion, this study provides experimental evidence that tempol resolved urinary concentration defect by the restoration of AQP, AVP and KIM-1 levels indicating a potential use of tempol in ameliorating the AKI in cancer patients under the treatment with CP.
引用
收藏
页码:1355 / 1363
页数:9
相关论文
共 44 条
[1]   Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation [J].
Abdel-Wahab, Wessam M. ;
Moussa, Farouzia, I .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :1155-1162
[2]   S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11 and TNF-α in mice [J].
Abdi, Sayed Aliul Hasan ;
Afjal, Mohd Amir ;
Najmi, Abul Kalam ;
Raisuddin, Sheikh .
PHARMACOLOGICAL REPORTS, 2018, 70 (04) :769-776
[3]   Anti-inflammatory role of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) in nephroprotection [J].
Afjal, M. A. ;
Abdi, S. A. Hasan ;
Sharma, S. ;
Ahmad, S. ;
Fatima, M. ;
Dabeer, S. ;
Akhter, J. ;
Raisuddin, S. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2019, 38 (06) :713-723
[4]   Tempol, a Superoxide Dismutase Mimetic Agent, Ameliorates Cisplatin-Induced Nephrotoxicity through Alleviation of Mitochondrial Dysfunction in Mice (vol 9, e108889, 2014) [J].
Ahmed, L. A. ;
Shehata, N., I ;
Abdelkader, N. F. ;
Khattab, M. M. .
PLOS ONE, 2014, 9 (12)
[5]   Tempol prevents genotoxicity induced by vorinostat: role of oxidative DNA damage [J].
Alzoubi, Karem H. ;
Khabour, Omar F. ;
Jaber, Aya G. ;
Al-azzam, Sayer I. ;
Mhaidat, Nizar M. ;
Masadeh, Majed M. .
CYTOTECHNOLOGY, 2014, 66 (03) :449-455
[6]  
Arunkumar P. A., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P640, DOI 10.1016/S2221-1691(12)60112-9
[7]   Cisplatin: a review of toxicities and therapeutic applications [J].
Barabas, K. ;
Milner, R. ;
Lurie, D. ;
Adin, C. .
VETERINARY AND COMPARATIVE ONCOLOGY, 2008, 6 (01) :1-18
[8]   Tempol, a Superoxide Dismutase Mimetic Agent, Inhibits Superoxide Anion-Induced Inflammatory Pain in Mice [J].
Bernardy, Catia C. F. ;
Zarpelon, Ana C. ;
Pinho-Ribeiro, Felipe A. ;
Calixto-Campos, Cassia ;
Carvalho, Thacyana T. ;
Fattori, Victor ;
Borghi, Sergio M. ;
Casagrande, Rubia ;
Verri, Waldiceu A., Jr. .
BIOMED RESEARCH INTERNATIONAL, 2017, 2017
[9]   Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more [J].
Bonventre, Joseph V. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (11) :3265-3268
[10]   The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments [J].
Bustin, Stephen A. ;
Benes, Vladimir ;
Garson, Jeremy A. ;
Hellemans, Jan ;
Huggett, Jim ;
Kubista, Mikael ;
Mueller, Reinhold ;
Nolan, Tania ;
Pfaffl, Michael W. ;
Shipley, Gregory L. ;
Vandesompele, Jo ;
Wittwer, Carl T. .
CLINICAL CHEMISTRY, 2009, 55 (04) :611-622